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Abstract: Iron oxide nanoparticles (IONPs) have been employed for hyperthermia   treatments, 
stem cell therapies, cell labeling, and imaging modalities. The biocompatibility and cytotoxic 
effects of iron oxide nanoparticles when used in biomedical applications, however, are an 
ongoing concern. Endothelial cells have a critical role in this research dealing with tumors, 
cardiovascular disease and inflammation. However, there is little information dealing with 
the biologic effects of IONPs on the endothelial cell. This paper deals with the influence of 
dextran and citric acid coated IONPs on the behavior and function of human umbilical vein 
endothelial cells (HUVECs). After exposing endothelial cells to IONPs, dose-dependent effects 
on HUVECs viability, cytoskeleton and function were determined. Both citric acid and dex-
tran coated particles appeared to be largely internalized by HUVECs through endocytosis and 
contribute to eventual cell death possibly by apoptosis. Cytoskeletal structures were greatly 
disrupted, as evidenced by diminished vinculin spots, and disorganized actin fiber and tubulin 
networks. The capacity of HUVECs to form a vascular network on Matrigel™ diminished after 
exposure to IONPs. Cell migration/invasion were inhibited significantly even at very low iron 
concentrations (0.1 mM). The results of this study indicate the great importance of thoroughly 
understanding nanoparticle-cell interactions, and the potential to exploit this understanding in 
tumor therapy applications involving IONPs as thermo/chemoembolization agents.
Keywords: iron oxide nanoparticles, cytotoxicity, in vitro test, cytoskeleton, human umbilical 
vein endothelial cell
Introduction
Magnetic iron oxide nanoparticles are a promising tool for cell tracking, cell targeted 
drug delivery, transfection and diagnostics agents.1–4 In addition, there are potential 
applications in magnetic intracellular/interstitial hyperthermia.5–7 To date, a wide 
variety of magnetic nanoparticles have been produced, differing in size and type of 
coating material, including dextran, citrate, starch, albumin, silicones and   polyethylene 
glycol (PEG).8,9 Particle size and surface modification lead to different responses in 
terms of cell nonspecific or receptor-mediated uptake to iron oxide nanoparticles 
IONPs.10–12 It is well known that IONPs can be taken up into the reticuloendothelial 
system (RES) by endocytosis or phagocytosis. IONPs are also taken up by phagocytic 
cells such as monocytes, macrophages, and oligodendroglial cells. As discovered in 
research concerning atherosclerosis and stem cell labeling, IONPs can also be found 
in the endothelial cells.13,14
Previous studies have reported the cytotoxic effects of IONPs on the cytoskeleton 
of growing neurons and human melanoma cells.15,16 Although there are numerous International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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reports concerning the use of IONPs labeled endothelial 
progenitor/stem cells for imaging techniques and the induc-
tion of hyperthermia by intravascular administration of fer-
romagnetic particles, there is little information in concerning 
the effect of this loading on endothelial cell behavior and 
function.17–20 Angiogenesis is a hallmark of cancer, ischemic 
and inflammatory diseases and the endothelial cell is a key cell 
labeled with IONP in research on tumor growth/  metastasis and 
atherosclerosis. Thus, it is essential that the biological effects 
of IONPs on the endothelial cell be assessed.
Since bare IONPs are highly unstable in saline solutions, 
forming optically visible aggregates, we chose dextran and 
citric acid coated IONPs to observe the interaction of IONPs 
on human umbilical vein endothelial cells (HUVECs).21 
Both coating materials are commonly used for stabilizing 
and functionalizing IONPs for biomedical applications.22,23 
The aim of this study is to understand the in vitro interac-
tions between nanoparticles and endothelial cells in terms 
of particle uptake, and the effects on cell proliferation, 
the cytoskeleton (F-actin, vinculin and tubulin), cell dif-
ferentiation, cell migration, and invasion. This information 
will inform future research on endothelial cell-labeling and 
cancer-related hyperthermia treatments.
Materials and methods
Nanoparticle synthesis
Magnetite IONPs were prepared in situ by co-precipitation 
from an iron-dextran or citric acid solution according to stan-
dard co-precipitation techniques. Briefly, 2 starting solutions 
were made by adding 0.60 g of FeCl3·6H2O to 2 mL of deion-
ized (DI) water and, separately, adding 0.21 g of FeCl2·4H2O 
to 0.5 mL of a 2M solution of HCl. These solutions were 
then added to 10 mL of DI water with 0.372 g citric acid 
or 1 g dextran with vigorous stirring. The resulting solution 
mixture was titrated with 2 mL of a 5 M sodium hydroxide 
with vigorous stirring for 30 minutes during which a black 
precipitate formed, indicating the formation of a Fe3O4 
nanoparticle colloidal suspension. This solution was heated 
to 80°C and kept for 2 hours and then centrifuged at 900 × g 
for 5 minutes. The supernatant was then removed before 
the nanoparticles were dispersed in DI water. This washing 
process was repeated 4 additional times and the centrifugate 
was finally dispersed in 10 mL of DI water.
Nanoparticle characterization
The average particle size and distribution were determined 
using transmission electronic microscopy (TEM) (JEOL, 
Tokyo, Japan). The aqueous dispersion of the particles 
was drop cast onto a carbon coated copper grid, which was 
subsequently air dried at room temperature before loading 
into the microscope. The lyophilized IONPs were ground 
with KBr for FT-IR measurement by a Nicolet 6700 Fourier 
transformed infrared spectrometer (Thermo, Waltham, MA, 
USA). Samples of blank iron oxide particles prepared in 
parallel, under the same conditions although without coating 
materials were utilized as a control.
cell culture
HUVECs were purchased from Cascade Biologics (  Portland, 
OR, USA) and cultured in Medium 200 containing: 
10% fetal bovine serum; 1% L-glutamin (200 mM); 1% 
  penicillin (100 U/mL); and 1% streptomycin (100 µg/mL); 
supplemented with Low Serum Growth Supplement (LSGS) 
in a 5% CO2 incubator at 100% humidity and a temperature 
of 37°C. The cells were regularly monitored using an inverted 
light microscope, and the culture medium was changed 3 times 
a week. To deliver IONPs into HUVECs, cells were plated 
at a density of approximately 2 × 104 cells/mL into 6-well 
plates or seeded on glass coverslips, which were then allowed 
to adhere overnight. The following day, cells were washed and 
incubated in complete medium, supplemented with IONPs at 
different concentrations, for 1 hour (iron concentration was 
confirmed by atomic absorption spectroscopy). All control 
cells were cultured in the absence of any particles.
In vitro cell viability assay
The MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltet-
razolium bromide, a tetrazole) assay is very often used to 
evaluate cell proliferation and the viability for biomaterial 
toxicity.24 The MTT assay relies on reading the absorbance 
of formazan and might be affected by the adhesion or non-
specific adhesion of IONPs. Live cells have intracellular 
esterases that convert nonfluorescent, cell-permeable, calcein 
acetoxymethyl ester (calcein AM) to the intensely fluorescent 
green calcein which is retained within the cells. The toxic-
ity level of IONPs was assessed by the calcein AM assay. 
The iron concentration to be tested was from 0.03–20 mM 
(as given in the literature).15,25,26 In our experiment iron 
concentrations from 0.08–20 mM were adjusted to test the 
cytotoxicity of the IONPs. HUVEC cells were seeded at a 
density of 1 × 104 cells/well in a 96-well tissue culture plate 
(BD Biosciences, Franklin Lakes, NJ, USA) and incubated 
overnight. Following starvation with 1% serum in medium 
for 24 hours, cells were treated with IONPs at a concentration 
from 0.1 to 20 mM for 1, 6 and 24 hours, in quadruplets, in the 
complete medium. Control cells were used without   particle International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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treatment. At the end of each exposure, the medium was 
removed and the cells were washed 3 times with phosphate 
buffered saline (PBS). The green calcein was measured at 
494/517 nm using a microplate reader. All experiments were 
performed 3 times and in quadruplets, with the average of all 
the experiments being shown as a cell-viability percentage 
in comparison with the control cells, which were considered 
as 100% viable.
Prussian blue staining  
of intracellular IONPs
For Prussian blue staining, the cells were incubated with 
IONPs at concentrations of 0.1 and 1 mM for 1 hour. After 
incubation, the culture medium was removed. The adher-
ent cells were washed 3 times with PBS (0.1 M, pH 7.4), 
trypsinized, and centrifuged for 10 minutes at 1500 rpm. The 
number of cells was determined using a Neubauer counting 
chamber. After growing overnight in six-well plates with 
glass coverslips, HUVECs were washed 3 times with PBS, 
and subsequently fixed with 4% paraformaldehyde/PBS. 
Following this the fixed cells were incubated with 10% 
potassium ferrocyanide for 5 minutes, with 10% potassium 
ferrocyanide in 20% hydrochloric acid for 30 minutes, and 
counterstained with nuclear fast red.
Visualization of intracellular  
IONPs by TeM
For cell samples, the cells were seeded into six-well plates 
and grown overnight. One hour after exposure to IONPs of 
0.1 and 1 mM, cells were collected and fixed in an aqueous 
solution of 2.5% glutaraldehyde in PBS (pH 7.0) for more 
than 4 hours before being washed 3 times in the phosphate 
buffer; they were then postfixed with 1% osmium tetroxide 
in phosphate buffer (pH 7.0) for 1 hour. Following this they 
were again washed three times in the phosphate buffer. 
The samples were dehydrated by a graded series of ethanol 
(50%, 70%, 80%, 90%, 95% and 100%) for approximately 
15–20 minutes for each step, and then transferred to absolute 
acetone for 20 minutes. Later, the samples were infiltrated 
with a 1:1 mixture of absolute acetone and the final Spurr 
resin mixture for 1 hour at room temperature before being 
transferred to a 1:3 mixture of absolute acetone and the final 
resin mixture for 3 hours, and then to the Spurr resin mix-
ture overnight. Samples were placed in capsules containing 
embedding medium and heated at 70°C for about 9 hours, 
following this they were stained with uranyl acetate and alka-
line lead citrate for 15 minutes each, before being observed 
using a TEM (JEOL, Tokyo, Japan).
Fluorescent cytoskeleton and focal 
adhesion kinase (FAK) observation
Cells were seeded on the coverslips and grown overnight. 
After 1 hour culture with IONPs under the conditions 
described previously, cells were washed with PBS and 
fixed in 4% paraformaldehyde/PBS at room temperature 
for 15 minutes. After this they were washed again with PBS 
and permeated with Triton X-100/PBS for 5 minutes before 
finally being incubated in 1% BSA/PBS for 30 minutes. 
This was followed by the addition of either anti-vinculin, a 
protein associated with focal adhesion kinase (FAK) primary 
antibody (1:100 in 1% BSA/PBS, monoclonal antihuman 
raised in mouse [IgG1], Chemicon, CA, USA) for 1 hour at 
37°C or anti-tubulin antibody to observe microtubules. The 
samples were then washed in 0.5% Tween 20/PBS, and a 
secondary FITC-conjugated antibody (1:50 in 1% BSA/PBS, 
monoclonal goat anti-mouse [IgG], Chemicon, CA, USA) 
was added for 1 hour at 37°C followed by washing. For 
F-actin stain, rhodamine conjugated phalloidin was added 
for the duration of this incubation simultaneously (1:100 
in 1% BSA/PBS, Chemicon, CA, USA). After mounting the 
coverslip with antifading mounting medium (Vector H1200, 
Burlingame, CA, USA), samples were then viewed by laser 
confocal microscope (Leica Tcs, Mannheim, Germany).
In vitro vasculogenesis assay
In vitro vasculogenesis was assessed as the formation of 
capillary-like structures by the HUVECs. The experimental 
procedure followed the instructions provided with the tube 
formation kit (Chemicon, CA, USA). To observe the treat-
ment effect of IONPs, HUVECs were exposed to the IONPs 
for 1hour at iron concentrations of 0.1 and 1 mM. After 
IONPs exposure, 1 × 104 control cells and treated HUVECs 
were loaded on Matrigel and incubated at 37°C, in growth 
medium containing low growth serum supplement (LSGS) 
for 8–12 hours to allow cellular network structures to fully 
develop. The formation of the tubular structures was moni-
tored by calcein AM stain. Calcein-AM 10 µL (1 nM) was 
added to each well and incubated for 15 minutes, before 
being washed with PBS 3 times and then being observed 
using a fluorescence microscope (Olympus IX71, Tokyo, 
Japan).
hUVecs migration and invasion assay
The migration assay was carried out with a modified Boy-
den chamber according to the kit instructions   (Chemicon, 
CA, USA). Confluent HUVECs monolayers were cultured 
with non-growth factor-containing media for 24 hours International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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and then supplemented with IONPs at the same iron 
  concentrations for an extra 1 hour incubation before harvest-
ing. Harvested cells were suspended at 106/mL in M200 with 
1% serum, and 105 cells were seeded into upper chamber 
(8 µm pore size of polycarbonate membrane). 10% serum 
medium was added into the lower chamber to stimulate the 
migration. Cells were allowed to migrate for 6–8 hours at 
37°C. Migration was terminated by flipping out the remain-
ing cell suspension from the upper compartment, and cells 
were dislodged completely from the underside. The extent 
of cell migration was determined by CyQuant GR Dye 
staining and read with a fluorescence plate reader using a 
480/520 nm filter set.
A cell invasion assay was performed in a 96-well invasion 
plate based on the Boyden chamber principle. The difference 
between the invasion and migration assay is a thin layer of 
extracellular matrix (ECM) coated on polycarbonate mem-
brane as the intervening invasive barrier. The ECM layer 
occludes the membrane pores, blocking non-invasive cells 
from migrating through. Invasive cells, on the other hand, 
degrade the ECM, migrate through the ECM layer and cling 
to the bottom of the polycarbonate membrane. Briefly, the 
invasion assay was tested as in the migration assay. Prior to 
being seeded into the upper chamber in Medium 200 with 
1% serum, cells were incubated with IONPs at 0.1 and 1 mM 
for 1 hour after starving for 24 hours. The effect of IONPs 
on endothelial invasion was observed by their movement 
from the upper chamber (low serum in medium of 1%) to 
the lower chamber (high serum in medium of 10%). After 
8 hours incubation, invading cells on the bottom of the insert 
membrane were dissociated from the membrane when incu-
bated with cell detachment buffer, and subsequently lysed 
and detected by CyQuant GR dye.
statistical evaluation
All results were expressed as mean ± standard deviation (SD). 
Statistical comparisons were performed using Student’s t-test 
(2-tailed) and two way ANOVA, a probability of P value 
, 0.05 was used to indicate a significant difference and 
P value , 0.01 to indicate a highly significant difference.
Results
Magnetic nanoparticle characterization
The TEM image of the magnetic nanoparticles was used 
to determine the shape, size and uniformity of the particles 
(Figures 1a and 1b). The figure shows that the particles 
were spherical shaped with an approximate core size 
of 38 ± 8.14 nm for citrate-IONP and 31 ± 6.58 nm for 
the dextran-IONP. The purified IONPs suspension was 
  lyophilized and   examined using FT-IR spectroscopy. As 
shown in Figure 1c, the 1700 cm−1 peak assignable to the 
C5O vibration from the COOH group of citric-acid shifted 
to an intense band at about 1614 cm−1, revealing the binding 
of a citric acid radical to the magnetite surface. The low-
intensity bands between 400 cm−1 and 600 cm−1 could be 
associated with the stretching and torsional vibration modes 
of the magnetite. In Figure 1d, there is an intense and broad 
band in the region of 3423 cm−1, which was assigned as the 
O-H stretching vibration, indicating the composite dextran-
IONP contained abundant of hydroxyl groups. (detailed 
FT-IR of iron oxide nanoparticles and coating material can 
be seen in Figures S1–S3).
In vitro cell viability assay
The viability assay of HUVECs showed that cell viability 
was affected in a concentration-dependent manner. The 
cytotoxicity of the nanoparticles increased with increasing 
iron concentration (Figure 2). The citrate-IONP has a sig-
nificant toxic effect on HUVECs viability compared with 
the dextran-IONP (two way ANOVA, P , 0.05). After 
6 hours incubation the toxic effect of citrate-IONP became 
much stronger than the dextran-IONP (two way ANOVA, 
P , 0.01). Overnight (24 hours) viability decreased less than 
50% at iron concentrations of 1 mM for both citrate-IONP 
and dextran-IONP (Figure S4).
Prussian blue stain of intracellular IONPs
Prussian blue stain (Figure 3) showed a strong uptake of 
IONPs after 1 hour incubation with different particles. The 
citrate-IONP and dextran-IONP particles appeared to be in 
clusters in the cell cytoplasm, partially around the nucleus and 
possibly located in endocytotic vesicles such as lysosomes. 
Additionally, cell detachment was observed after IONP incu-
bation and there were less cells for 1 mM IONP incubation 
than for 0.1 mM IONP incubation.
TeM of hUVecs after IONPs incubation
As previously stated, iron oxide nanoparticles have been 
shown to be readily taken up by a variety of cells via an 
endocytotic mechanism.10–16 The internalization of citrate-
IONP and dextran-IONP by HUVECs at iron concentrations 
of 0.1 mM and 1 mM was verified using TEM (Figure 4). 
Figure 4 shows a large number of IONPs within the cyto-
plasm, particularly in numerous endocytotic vesicles such as 
lysosomes, accumulating in the perinuclear region within the 
cells (Figures 4b and 4c). The beginning of the uptake was a International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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Figure 1 TeM images and FT-Ir spectra of composite iron oxide nanoparticles. 
Notes: (a, b) TeM of citrate and dextran-coated IONP; (c, d) FT-Ir spectrum of citrate and dextran-coated IONP.
Abbreviations: IONP, iron oxide nanoparticles; TeM, transmission electron microscope; FT-Ir, Fourier transformed infrared spectroscopy.
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Figure 2 (a) cell viability of citrate-IONP on hUVecs after 1, 6 and 24 hours. (b) cell viability of dextran-IONP on hUVecs after 1, 6 and 24 hours.
Notes: Percentage of viability of hUVecs was expressed relative to control cells (n = 3).
Abbreviations: hUVecs, human umbilical vein endothelial cells; IONP, iron oxide nanoparticles.
pit formation of the membrane and the lysosomes increased 
with higher iron concentrations. In addition, there were many 
vacuoles within the cytosol (Figures 4d and 4e) and abnormal 
dense filament matter (Figures 4f and 4g) appeared near the 
nucleus, indicating an active cell response to IONPs at the 
higher iron   concentration of 1 mM.
Alteration of cytoskeleton and FAK
In addition to HUVEC cell proliferation, the phenotype and 
cytoskeleton were also affected by increasing concentra-
tions of IONPs. The changes in morphology and cytoskel-
etal structure of cells exposed to varying levels of IONPs 
were investigated using a fluorescence stain for vinculin International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
Dovepress 
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Figure 3 Prussian blue stained and nucleus fast red counterstained hUVecs incubated without or with different IONP samples. (×200 magnification).
Notes: (a) control: without any particles; (b, d) with citrate-IONP; (c, e) with dextran-IONP; (b, c) cells were incubated with IONPs at iron concentration of 0.1 nM;   
(d, e) cells were incubated IONPs at iron concentration of 1 nM.
Abbreviations: hUVecs, human umbilical vein endothelial cells; IONP, iron oxide nanoparticles.
(FITC, green), F- actin (TRITC, red) and β-tubulin (FITC, 
green). Typically, untreated HUVEC cells are flat adherent 
to the substratum with clear vinculin and strong peripheral 
F-actin staining along the cell edge, indicative of cortical 
actin fibers (Figures 5a–5c). After 1 hour incubation with 
dextran-IONPs, cells exhibited small and round cell mor-
phology, with F-actin appearing thinner and less organized 
within the main body (Figures 5e–5g). Furthermore, the cells 
incubated with citrate-IONP not only exhibited a smaller 
and more irregular cell morphology with vacuoles appearing 
within the cytoplasm, they also showed a flurry cell edge 
with diminished vinculin spots within the cells, indicat-
ing a reduction in stress fibers/FAK and the lamella actin 
network (Figures 5i–5k). The microtubular change caused 
by IONP internalization was further shown by β-tubulin 
stain. The microtubules formed a dense network almost 
equally distributed around the nucleus of the control cells 
(Figure 5d). Incubation with dextran-IONP resulted in 
the disruption of microtubule structures in the central and 
peripheral domain compared with control cells (Figure 5h). 
The effect of citrate-IONP exposure was demonstrated by 
a diffused tubulin stain and a shorter long axis, suggesting 
interference with polymerization and depolymerization. 
This result confirms a disorganization of the cytoskel-
eton due to the treatment with iron oxide nanoparticles. 
This disorganization could cause a series of signal pathway 
  disruptions, thus minimizing cell surface area and contact 
with the environment. Due to a severe detachment response 
of cells to particle incubation, cells were retracted and the 
fine structure could not be exhibited in a clear way.
In vitro vasculogenesis assay
Vascular endothelial cells will proliferate when cultured in 
the appropriate medium; however, they will not differentiate 
and form tube-like structures until they are presented with the 
appropriate cues, like collagen or fibronectin (Figure 6a).27,28 
The formation of tubes by endothelial cells is a critical 
step in angiogenesis. The endothelial cell vasculogenesis 
assay was performed to examine the ability of the treated 
HUVEC cells to produce capillary-like tubular structures. 
The formation of the tubular structures was monitored by 
fluorescence microscopy with the calcein AM stain. For con-
trol cells, early cell junctions were observed between 1 and 
2 hours after cell adhesion, the final geometrical network 
appearing prominently about 6 hours after cell adhesion. 
Cell structures then became slimmer with time (Figure 6b). 
However, for 0.1 mM IONPs treated cells the kinetics of 
network formation was altered greatly, with little to no tube 
structure being found after seeding on the Matrigel, though 
the cells were still alive (Figures 6c and 6d). There were International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
Dovepress 
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Figure 4 TeM of hUVecs incubated with IONPs for one hour, (×8000 magnification). 
Notes: (a) control cell (without incubation of any particles); (b, d, f) with citrate-IONP; (c, e, g) with dextran-IONP; (b, c) cells were incubated with IONPs at iron 
concentration of 0.1 nM; (d–g) cells were incubated with IONPs at iron concentration of 1 nM; (b, c) Particles were taken up into lysosomes; (d, e) Many vacuoles could be 
found in cytoplasm; (f, g) Abnormal dense filament matter appeared adjacent to vacuoles (yellow arrow: IONPs, black arrow: vacuoles, rectangular: filaments, L: lysosome).
Abbreviations: IONP, iron oxide nanoparticles; TeM, transmission electron microscope; hUVecs, human umbilical vein endothelial cells.
no tubular structures on the Matrigel after incubation with 
1 mM IONPs.
hUVecs migration and invasion assay
HUVEC migration in a modified Boyden chamber was 
a chemotactic model of migration representative of 
  tumor-induced endothelial cell migration. Stimulation of 
HUVECs along a directional gradient of serum resulted in 
the migration to the underside of the membrane, and this 
was inhibited in a concentration-dependent manner by 
IONP. Addition of IONP significantly reduced the migra-
tion of HUVECs, the number of migrated cells more greatly 
inhibited by citrate-IONP at the concentration of 0.1 mM 
(Figure 7). Due to the apparent toxic effect to cells, the 
inhibition capacity was not remarkably different at an iron 
concentration of 1 mM.International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
Dovepress 
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Figure 5 hUVecs were stained for F-actin (red), vinculin (green), nucleus (blue) and β-tubulin (green) with or without IONPs incubation, (×13000 magnification).
Notes: (a–d) Untreated control cell; (e–h) One hour incubation with dextran-IONP at 0.1 mM; (i–l) One hour incubation with citrate-IONP at 0.1 mM.
Abbreviations: hUVecs, human umbilical vein endothelial cells; IONP, iron oxide nanoparticles.
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Figure 6 Vasculogenesis in vitro with hUVec in different culture conditions (stained by calcein AM, ×100 magnification).
Notes: (a) cells were seeded on 96-well plate without Matrigel; (b) hUVecs which grew on Matrigel developed a geometrical network about 6 hours after cell adhesion; 
(c) dextran-IONP treated cells provided a partially poorly developed branch elongated shape compared with the untreated cells; (d) citrate-IONP treated cells demonstrated 
no tendency for vascular network formation.
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Since IONP inhibited cell adhesion and migration, we 
investigated the effect of IONP on the invasion of endothelial 
cells as well, using ECM invasion chambers. Invasion is a 
multistep process that involves cell adhesion, degradation 
of the matrix and migration of cells through the degraded 
matrix. Invasion of HUVEC cells was inhibited by IONPs, 
suggesting the involvement of multiple dysfunctions of 
HUVECs in this process. Citrate-IONP had a significantly 
negative effect in comparison with the dextran-IONP at all 
incubation concentrations (Figure 8).
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Figure 7 Migration assay of hUVecs under incubation with IONPs for 1 hour.
Notes: (x
_
 ± SD, n = 3) *P , 0.05. hUVecs were incubated with IONPs at different iron concentrations, and cell migration greatly decreased compared with control cells. 
citrate-IONP reduced migration more than dextran-IONP at an iron concentration of 0.1 mM.
Abbreviations: hUVecs, human umbilical vein endothelial cells; IONP, iron oxide nanoparticles.
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Figure 8 Invasion assay of hUVecs under incubation with IONPs for 1 hour.
Notes: (x
_
 ± SD, n = 3) *P , 0.05, **P , 0.01. hUVec invasion through the matrix was inhibited compared to control cells. citrate-IONP had a stronger inhibition capacity 
than dextran-IONP (P , 0.05, 1 mM; P , 0.01, 0.1 mM).
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Discussion
After synthesis of the magnetic nanoparticles, surface 
  modification is required to make the particles soluble. Surface 
modification also prevents the destabilization and aggrega-
tion of the particles. Dextran and citric acid are the most com-
mon biocompatible materials used for surface coating, having 
been used for clinical trials or diagnosis, eg, VSOP C184 and 
ferumoxides.22,23 The endothelial cell is an important target in 
the study of arteriosclerosis and anti-angiogenesis therapy. 
We chose dextran and citric acid as coating materials to test 
the nanotoxic effects on HUVECs in order to understand the 
possible interaction between coated particles and endothelial 
cells. In our research, HUVECs can internalize large amounts 
of both citrate-IONP and dextran-IONP.
Acute cytotoxicity
Internalization after exposure to IONPs drastically affected 
HUVEC growth and proliferation. In our findings significant 
toxic effects were seen above the concentration of 1 mM 
since the HUVEC viability rate decreased below 50% after 
overnight exposure of IONPs. In the present case, the decease 
of cell proliferation is difficult to explain. One possible reason 
might be free radical generation through iron-catalyzed Haber-
Weiss reactions.29,30 The Haber-Weiss reaction, which makes 
use of Fenton chemistry, is now considered to be the major 
mechanism generating highly reactive hydroxyl radicals in 
biological systems. The Fenton reaction becomes noticeable 
at higher intracellular concentrations of iron salts.29 The free 
radicals could damage DNA, cell membrane, cytoskeleton 
and ECM, and also mediate signal transduction pathways 
directly or indirectly though bioactive mediators.29,31 Karlsson 
and colleagues suggested that IONP can cause low levels of 
toxicity due to the potency in causing oxidative DNA lesions 
in cultured A549 cells (the human lung epithelial cell line).32 
Citrate-coated IONP had much more capacity than dextran-
IONP to inhibit cell migration/invasion and proliferation, 
and rapid degradation of the particle shell might account for 
greater exposure of ferric cores, which contributes to citrate-
IONP’s greater toxic effect on HUVECs.
Another possible explanation for the toxic effects of 
IONP internalization is the apparent formation and migra-
tion of the IONPs containing endosomes/autophagosome 
to the proximal perinuclear region of the HUVECs. In cell 
biology, autophagy, or autophagocytosis, is a catabolic pro-
cess involving the degradation of a cell’s own components 
through the lysosomal machinery when induced by specific 
drugs or starving. It has been proposed that autophagy 
resulting in the total destruction of the cell is one of several 
types of programmed cell death. Observations that cells 
  possessing autophagic features in areas undergoing pro-
grammed cell death have led to the coining of the phrase 
autophagic cell death (also known as cytoplasmic cell death 
or type II cell death).33–35 The most well-known mechanism 
of autophagy involves the formation of a membrane around 
a targeted region of the cell, separating the contents from the 
rest of the cytoplasm. This was confirmed by many membrane 
structured vacuoles in the cytoplasm in the TEM images and 
under fluorescent staining (Figure 4 and Figure 5). It might 
be that the autophagocytosis under exposure to IONPs par-
tially caused cell morphology changes and final cell death 
(Supplementary Figures S5 and S6).
Alteration of the cytoskeleton and cell 
response to biological cues
From the results of cytoskeleton organization studies, we 
observed that both types of nanoparticles induced great 
changes in cytoskeleton organization and cell morphology, 
like cell retraction, rounding, disruption of F-actin and 
microtubules. Moreover, the F-actin microfilament and focal 
adhesion complex diminished under the treatment of citrate-
IONP, suggesting that coating material is closely related to 
the cell response to IONPs. Additionally, there were massive 
dense filament matters adjacent to the nucleus and vacuoles 
in the cytoplasm in TEM (Figures 4f and 4g). The expla-
nation for the phenomenon is that there is a link between 
cytoskeleton organization and the endocytosis process.36 
The relationship between the two processes might involve 
interactions between distinct protein complexes, depending 
on the nature of the particles being internalized.
Cell migration and invasion are multistep complex 
processes, requiring coordinated activities of cytoskeleton, 
membrane and adhesion systems.37–41 FAK-enhanced exter-
nal signals to actin are necessary to mediate the survival 
of anchorage-dependent cells and critical for efficient cell 
mobility in response to external stimulation.38,41 From our 
results, FAK decreased/diminished after IONPs incubation 
and the tight relationship between stress fibers and FAK 
disappeared (Figure 5). Those changes in the cytoskeleton 
assembly and FAK impeded cell signal transduction and 
impaired cell mobility. The eventual cell detachment also 
induced apoptosis by anoikis.42 Recent findings show that 
FAK contribute to the secretion of matrix-metalloproteinases 
and represent an important checkpoint in coordinating the 
dynamic processes of cell motility and extracellular matrix 
remodeling during cell invasion.43–45 This would be a sub-
stantial theory to explain why IONPs had stronger inhibition International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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on cell invasion than migration because the IONPs caused 
failure of ECM degradation, the most important step in the 
invasion process.
Vasculogenesis, the growth of the primary vascular 
network from initially dispersed endothelial cells, is the first 
step in the development of the circulatory system in verte-
brates. In vitro culture of HUVECs in Matrigel™ is a popular 
experimental model of capillary development. Matrigel is an 
extracellular matrix product obtained from murine tumors.46–48 
It is widely assumed that the adhesion-based activities are the 
key points for vasculogenesis.47 After sensing the extracellular 
proteins and growth factors in the gel, HUVECs are stimu-
lated to elongate and form networks (Figure 6b) resembling 
vascular networks in vivo, where cords of endothelial cells 
surround empty lacunae. After incubation with of IONPs, 
even at the lowest tested concentration, incubation appeared 
to affect cytoskeletal structure and inhibit maturation and 
the differentiation of HUVECs to form vascular structures 
(Figures 6c and 6d). The disruption of F-actin, FAK and 
tubulin caused by IONP incubation might contribute to the 
cell detachment and the failure of differentiation, since all 
these processes need the coordination of the cytoskeleton to 
complete complicated and sophisticated signal communica-
tion, which are cell adhesion, mobility and elongation.
Potential indication for cell labeling  
and cancer therapy
Magnetic iron oxide nanoparticles have been widely used to 
label stem cells or progenitor cells for cell tracking or targeted 
imaging in myocardial infarction or atherosclerosis. How-
ever, there has been little reported concern about cell behavior 
and function change after IONP labeling. In our experiment, 
cytoskeleton and cell motility capacity were greatly affected 
after IONP incubation at low iron concentration (0.1 mM), 
although cell viability did not significantly decrease. These 
findings should be taken into account when researchers 
observe cell motility or adhesion related parameters. A single 
cell viability assay is not enough to evaluate a nanotoxic 
effect and might underestimate cell-particle interaction if 
IONPs biologic effects are neglected. In our experiment, we 
compared citrate coating with dextran coating, quantitatively 
and qualitatively, considering cell proliferation, cytoskeleton 
and other related functional capacities. The results confirmed 
the view that an interaction might be cell type specific, and 
more attention should be given to the influence of particle 
surface modification and surface charge.9–12
Angiogenesis is a fundamental step in the transition of 
tumors from a dormant state to a malignant one and is crucial 
for tumor growth and metastasis; which requires an abundance 
of oxygen and nutrients to proliferate. Antiangiogenic 
therapies affect vascular structure and function in different 
ways to cut off the nutrient supply and cause the tumor to 
regress. IONPs have been used as a carrier to deliver the toxic 
drug (eg, doxorubicin) to target sites by applying an external 
magnet, and IONPs have been injected into tumor vascular 
systems as a hyperthermia agent.3,20 In our experiment, we 
revealed that low concentrations of IONPs effectively induce 
a decrease of HUVECs viability and inhibited HUVECs 
differentiation and migration/invasion. This might have the 
potential to be used as an optional cost-effective alternative 
chemotherapy by transcatheter arterial embolization and 
hyperthermia without complex drug design.
Conclusion
In summary, this study has demonstrated that exposure to 
IONPs results in a dose-dependent decrease of HUVECs viabil-
ity and inhibits their differentiation on Matrigel and migration/
invasion to stimulus factors. The results confirm that the toxicity 
of IONPs affect the biocompatibility and biosafety for in vivo 
or in vitro experiments. On the other hand, a toxic effect might 
be applied to tumor therapy, with measures to deal with the 
safety and feasibility. Although it was found that cytoskeleton 
organization and related cell function were interfered with, 
further studies into the physiochemical basis involved in cell 
phagocytosis and transportation of IONPs may help to elucidate 
the mechanisms of this interference to a greater degree.
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Figure S4 Optical microscopy of hUVecs incubated without or with different IONPs for 24 h. (a) control cell without any particles; (b–d) cells were incubated with citrate-
IONP at iron concentration of 0.1, 1 and 10 nM; (e–g) cells were incubated with dextran-IONP at iron concentration of 0.1, 1 and 10 nM.International Journal of Nanomedicine
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Figure S5 Annexin V kit fluorescent staining of HUVECs incubated without or with different IONPs for 6 h. (a) control cells without any particles; (b, d) with citrate-IONP; 
(d, e) with dextran-IONP; (b, c) cells were incubated with IONPs at iron concentrations of 0.1 nM. cells were incubated with IONPs at iron concentration of 1 nM. Arrows 
denote possible apoptotic cells. Bar 100 μm.
40
35
30
25
20
15
10
5
0
control Citrate-IONP Dextran-IONP
0.1 nM
1 nM
Figure S6 The percentage of apoptotic cells were counted and expressed graphically after 6 h exposure to IONPs.